A team of Japanese researchers said they have succeeded in separating and killing a subgroup of drug-tolerant breast cancer stem cells by using existing medicines currently used for heart failure.
About the Author
A team of Japanese researchers said they have succeeded in separating and killing a subgroup of drug-tolerant breast cancer stem cells by using existing medicines currently used for heart failure.
